Yiqiang Li – Trademark Portfolio

Entity Type: 01

Yiqiang Li holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include ZGLINK. The owner is based in Yangjiang, Guangdong.

No.27-3, Shuiwen Village, Pingyuan Village Committee, Chengcun Town, Yangxi County

Yangjiang, Guangdong 529822 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FERNOVA
FERNOVA
Pending 2026
ZGLINK
ZGLINK
Registered 2025

Trademark Classifications

Yiqiang Li's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Yiqiang Li have?

Yiqiang Li has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does Yiqiang Li file in?

Yiqiang Li files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Yiqiang Li's most well-known trademarks?

Yiqiang Li's registered trademark portfolio includes well-known marks such as ZGLINK. These are among 1 currently registered trademark in the portfolio.

What is Yiqiang Li's trademark registration success rate?

Yiqiang Li has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.